Mirum Pharmaceuticals, Inc.
MIRMNASDAQHealthcare● Active
$93.48
+$0.99(+1.07%)
Market Cap$4.7B
P/E Ratio—
52W High$114.99
52W Low$43.5
Mirum Pharmaceuticals, Inc.（MIRM）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · MIRM · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.52B | $0.34B | $0.19B | $0.08B | $0.02B |
| Cost of Revenue | $0.10B | $0.08B | $0.05B | $0.01B | $0.00B |
| Gross Profit | $0.42B | $0.26B | $0.14B | $0.06B | $0.02B |
| Gross Margin %(computed) | 80.71% | 75.77% | 74.76% | 83.94% | 90.06% |
| Operating Expenses | |||||
| R&D Expenses | $0.19B | $0.14B | $0.10B | $0.11B | $0.13B |
| G&A Expenses | $0.00B | $0.19B | $0.14B | $0.00B | $0.05B |
| Total Operating Expenses | $0.44B | $0.34B | $0.25B | $0.20B | $0.19B |
| Operating Income | ($0.02B) | ($0.09B) | ($0.11B) | ($0.13B) | ($0.17B) |
| Operating Margin %(computed) | -4.25% | -26.00% | -58.57% | -170.28% | -906.12% |
| Interest Income | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.02B | $0.02B | $0.02B |
| Income Before Tax | ($0.02B) | ($0.09B) | ($0.16B) | ($0.14B) | ($0.08B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | ($0.01B) | $0.00B |
| Net Income | ($0.02B) | ($0.09B) | ($0.16B) | ($0.14B) | ($0.08B) |
| Net Margin %(computed) | -4.48% | -26.10% | -87.68% | -176.05% | -438.85% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.47 | $-1.85 | $-4.00 | $-4.01 | $-2.77 |
| Wtd Avg Shares | 0.05B | 0.05B | 0.04B | 0.03B | 0.03B |
| EBITDA | $0.02B | ($0.05B) | ($0.14B) | ($0.12B) | ($0.07B) |
| EBITDA Margin %(computed) | 3.30% | -14.54% | -73.23% | -159.42% | -341.66% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Mirum Pharmaceuticals, Inc.
关于Mirum Pharmaceuticals, Inc.（MIRM）损益表
Mirum Pharmaceuticals, Inc.（MIRM）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，MIRM实现营收$0.52B，毛利润$0.42B（毛利率80.71%），净利润($0.02B)（净利率-4.48%）。
常见问题
MIRM · 4 问Mirum Pharmaceuticals, Inc.（MIRM）2025财年营收为$0.52B，同比up54.7%。
MIRM revenueMIRM salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08